Global Allied Pharmaceuticals

Global Allied Pharmaceuticals is a BPO/CRO/Global Consulting Group. We provide the following categorical commodities:

  1. Clinical Research Organizations (CRO)

  2. Information Technologies 

  3. Market Research

  4. Marketing : Advertising & Medical Education Services

  5. Professional Services

  6. Temporary Services & Staffing

  7. Training

We are well positioned; both domestically and internationally, to provide consistent and exceptional services.

Our global presence include: India, China, S. America and Common Wealth of Russia and Ukraine. In light of the recent global corporate acquisitions; we have expanded our industry presence. Global Allied Pharmaceuticals is empowered by 2145 highly competent full time employees (FTE's).

A great number of our associates are well seasoned with an average of 15 years of industry experience. Our least experienced associate has served this industry for more than three (3) years. We pride ourselves with the lowest attrition rate in the industry. This is an unmatched level of expertise and competence.

 Technical Expertise, Proven Track Record, Effective Project Execution at the global level are to say a few in our behalf. The robust presence of the teams of professionals include: Clinical Trial Development (i.e. the comprehensive launching and management of phases I- IV, supporting the NDA/BLA, ANDA, 510K, and PMA process), Medical Affairs (launching, support, etc.) Regulatory (full support, submission, technical staffing), Sales (technical augmentation/staffing, Logistics, management and deployment) and Marketing Efforts (support, training, strategic management), as well as Joint Ventures (VC, commercial ventures, acquisitions, etc.).

We are proud of our 728 CRA's, 269 PM's, 138 SAS program managers and Biostatisticians, 71 MD's, 37 upper management and strategic leaders. We have the logistical capability to quadruple our force within 3 months period.

We recently developed and deployed 23 MSL's (domestically and internationally), performed 3 complete NDA/BLA submissions with the management of its directed Risk Evaluation & Mitigation Strategies (REMS) in safety, processed more than 49092 individual cases annually, performed the surveillance activities and aggregate reporting of over 241 products; domestically and internationally. The clinical global recruitment is at its highest level today. There has been a total of 51298 treated participants in our trails annually over the past 3 years.

Please visit our corporate overview.